plasmasol


Also found in: Medical, Encyclopedia.

plas·ma·sol

 (plăz′mə-sôl′, -sŏl′, -sōl′)
n.
A state of cytoplasm that is more liquid than plasmagel.

plasmasol

(ˈplæzməˌsɒl)
n
(Biology) another name for endoplasm

plas•ma•sol

(ˈplæz məˌsɔl, -ˌsɒl)

n.
the inner, relatively fluid cytoplasm of the ameba.
[1920–25]
References in periodicals archive ?
Stevens has engaged its community of faculty, students, alumni and administration in a process of academic entrepreneurship that has paved the way for the development of patented disruptive technologies as well as the launch of award winning start-up companies like PlasmaSol and Hydroglobe that are benefiting our society and the global market," explains Dr.
Panels will focus on the topics of investment, featuring venture capitalists, angel investors, and license/business development officers, who will discuss what they look for from very early stage technology and life science companies; and Success Stories, which will feature a technology company, PlasmaSol, and a life science company, PTC Therapeutics.
Liverpool-born Paul Morrison's Plasmasol is a giant black and white acrylic of, well, a flower.
9 million charge to write off purchased in-process research and development associated with the acquisition of PlasmaSol Corp.
He is a co-founder of two technology commercialization companies, PlasmaSol Corporation and HydroGlobe, both of which have been acquired by global industrial groups.
The effective income tax rate for the year ended December 31, 2005 also reflects the non-deductibility for income tax purposes of the purchased in-process research and development charge associated with the acquisition of PlasmaSol Corp.
Shinneman, 56, was most recently president of PlasmaSol Corporation, the sale of which he successfully negotiated with Stryker Instruments late last year.
The Company acquired, by merger, all of the outstanding stock of PlasmaSol Corp.
3 /PRNewswire-FirstCall/ -- Stryker Corporation announced that on December 30, 2005, it acquired, by merger, all of the outstanding stock of PlasmaSol Corporation, a private, development stage company.